2025 Annual Meeting | C162 - Epilepsy: Surgery and Neuromodulation

Date Tuesday 04/08/25

Time 03:30 PM - 05:30 PM PDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Vikram Rao, MD

Topic(s) Epilepsy/Clinical Neurophysiology (EEG)

Learning Objectives Participants will be able to identify and describe diverse treatment options for drug-resistant epilepsy, including resective and ablative surgery and neuromodulation devices, and appraise evidence supporting the efficacy of these therapies, compare and contrast their intrinsic characteristics, and learn to formulate personalized treatment plans that relate to patient-specific factors and help achieve optimal clinical outcomes.

This program is supported in part by an educational grant from LivaNova USA, Inc.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Case-based, Didactic

Event Timeline
03:30 PM - 03:35 PM PDT	Introduction	Surgery vs. Neuromodulation: Decision-making in Drug-resistant Epilepsy Vikram Rao, MD
03:35 PM - 04:25 PM PDT	Speaker	Surgical Therapies for Epilepsy Barbara C. Jobst, MD, PhD, FAAN
04:25 PM - 05:15 PM PDT	Speaker	Neuromodulation Therapies for Epilepsy Shruti Agashe, MD
05:15 PM - 05:30 PM PDT	Discussion	Putting It All Together for Personalized Epilepsy Treatment Vikram Rao, MD

Faculty Disclosures
Barbara C. Jobst, MD, PhD, FAAN	Dr. Jobst has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Jobst has received research support from Neuropace, Inc.. The institution of Dr. Jobst has received research support from NIH. The institution of Dr. Jobst has received research support from CDC.
Vikram Rao, MD	Dr. Rao has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precisis GmbH. Dr. Rao has received personal compensation in the range of $500-$4,999 for serving as a Consultant for iVEAcare. Dr. Rao has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Echo Neurotechnologies. Dr. Rao has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuroPace, Inc.. Dr. Rao has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Rao has or had stock in Novela Neurotechnologies.Dr. Rao has or had stock in EnlitenAI.Dr. Rao has or had stock in Doximity, Inc.Dr. Rao has or had stock in Theta Neurotech.Dr. Rao has or had stock in Encephalogix.Dr. Rao has or had stock in Echo Neurotechnologies.
Shruti Agashe, MD	Dr. Agashe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Blackrock.

��ɫ��

��ɫ��